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Is it important to consider sex and gender in neurocognitive, neurobiological, and clinical stud-
ies? I refer here to “sex” as a biological variable related mainly to sex chromosomes and sex
steroid hormones, while “gender” stands for a psychosociocultural construct related to gender
role socialization, levels of masculinity and femininity, and stress related to adhesion to gen-
der stereotypes. It is a rhetorical question and I hope that an overwhelming majority of read-
ers would answer: “yes, of course!” However, despite the fact that more attention has been
devoted over the past decade to delineating differences between men and women in their neu-
roanatomy, neurophysiology, and cognitive and emotional processing (1, 2), a substantial num-
ber of researchers (basic and clinical) continue ignoring “the second sex” and study exclusively
males. The reasons are multiple and range from an unawareness, through a lack of sufficient
funding to examine both sexes, to the argument that the studies, to date, have not found any
significant sex differences in a given paradigm or disorder and therefore there is no need to
include both males and females in a study. Finally, there is a group of theorists who sees this
line of inquiry (i.e., investigating sex differences in the brain and cognition) as inherently biased,
thus contributing to some harmful stereotypes that may lead to increasing gender inequalities
[e.g., Ref. (3, 4)].
It is hard to argue with the lack of funds and indeed there are cognitive and clinical domains where
we have not seen any indication of potential sex or gender differences. Nevertheless, our technology
has improved and we possess more sensitive instrumentation, which may detect subtle differences
that were not previously apparent. Moreover, we must remember that men and women of today are
different from men and women of two or three decades ago. We are not only socialized differently,
due to changed family values and education, more competitive job market and prominence of
social media, but also exposed tomore environmental toxins, including endocrine disruptors, which
may affect our physical and mental health (5, 6). As to the harmful effects of some studies of the
neurobiological and cognitive sex differences, I agree that data are sometimes interpreted in a biased
manner andmay contribute to propagation of damaging gender stereotypes. However, I also believe
that excluding women is much more dangerous. We have seen the harm done with several drugs
released for treatment of various disorders without proper testing or consideration of women’s
physiology (e.g., Posicor, approved for the treatment of hypertension and angina, slowed or stopped
the heart rate especially in elderly women; antihistamines such as Seldane and Hismanal induced
cardiac arrhythmias disproportionally more frequently in women), but thankfully the situation is
changing (7, 8).
While it is true that men and women are much more alike than different and it actually
makes more sense to talk about sex and gender similarities (be it in brain structure or cognitive
function), there are those subtle differences that may provide clues to disentangling etiology of some
neurological and neuropsychiatric disorders, such as multiple sclerosis, autism, mood, and anxiety
disorders, or shed a new light on treatment of these conditions. In short, “vive la similarité, but
let’s explore differences!” I would like to use two clinical examples that I am most familiar with, to
illustrate my point – schizophrenia and drug addiction.
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Schizophrenia
The existence of sex differences in the prevalence, development,
and progression of schizophrenia was noted already by Kraepelin
and Bleuler who conceptualized and meticulously described the
disorder at the beginning of the twentieth century (9, 10). Possibly
because the prevalence of schizophrenia is greater in men than in
women during the first half of life (until about 40 years of age),
most studies forgot about women altogether – this despite the fact
that there is a second peak of new cases in women around the
age of menopause when they catch up with men in the prevalence
(11, 12). I was unaware of this bias when I started investigating
neural correlates of cognitive function in schizophrenia during
my graduate school years, but very soon afterwards, as an inde-
pendent researcher, it became clear that existing theories and
treatment of schizophrenia were based almost entirely on data
from male subjects (human and animal). This realization hit me
when I came across two intriguing research studies, which found
a neuroanatomical reversal of normal sexual dimorphism in the
anterior cingulate (13), amygdala, and orbitofrontal cortex (OFC)
(14). Due to my research familiarity with functional magnetic
resonance imaging (fMRI), I began to search for any fMRI stud-
ies of emotion processing in schizophrenia since the anterior
cingulate, amygdala, and OFC are all part of the corticolimbic
system heavily implicated in the experience and expression of
affect. I found numerous studies that met my search criteria, but
none of them examined sex differences as they included either
exclusively men, or the number of women was too small to allow
for any comparisons. This was almost a decade ago and it has
motivated our group to make an extra effort to recruit women
diagnosed with schizophrenia to our studies. We have conducted
several fMRI studies; some revealed reversal of normal sexual
dimorphism [e.g., during mental rotation task; (15)], others did
not find any sex or sex-specific differences [e.g., during passive
viewing of emotional stimuli; (16)], while a few found significant
relationship between brain activations and sex steroid hormones
[e.g., Ref. (17, 18)]. This line of research suggested to us that
there might be a subtype of schizophrenia patients where symp-
toms and related brain dysfunction is partly fostered by hor-
monal imbalance during organizational and/or activational stage
of neurodevelopment.
Thankfully, over the past decade the situation in the field
has changed; sex differences in schizophrenia are more widely
acknowledged and females (both animal and human) are more
frequently studied or at least included in the protocols. It is also
recognized thatwomenmight require lower doses of antipsychotic
medications during their reproductive years (due to interactions
between antipsychotic medications and estradiol) and that they
may benefit from low doses of estradiol or selective estrogen
receptor modulators (SERMs) (19). It is possible that factors con-
tributing to the development of schizophrenia and related psy-
chosis are slightly different inmen andwomenor that these factors
interact differently with the sexes. For example, perturbation in
the organizational effects of testosterone in utero could affect
male and female fetuses differently, and exposure to environmen-
tal toxins could affect endocrine systems of males and females
differently.
Drug Addiction
Drug addiction is another condition characterized by important
differences between men and women, and demonstrates how
research has changed over the past few decades. Somewhat sim-
ilarly to schizophrenia, traditionally drug abuse and dependence
have been considered a “male problem.” However, while the
prevalence of alcohol and cannabis dependence is still greater
among men, gender differences in the abuse of stimulants and
prescription drugs seem to have disappeared in theWestern world
(20). In addition, women appear to be more prone to develop
drug dependence, suffer more severe physical and psychologi-
cal consequences of drug abuse, and have a more difficult time
“kicking the habit” (21). The reasons for this gender gap include
a mixture of biological and psychosocial factors. For example,
while a larger proportion of men initiate drug use to induce
feelings of elation, energy or focus, women frequently start taking
drugs to alleviate pre-existing mental health problems, including
depression and anxiety (22). This maladaptive self-medication
strategy often results in a faster transition to a habitual drug use
and eventually a more severe dependence (23, 24). In addition,
the socio-cultural norms, particularly in theWestern society, have
changed dramatically over the past few decades. Thus, while there
is still a more severe stigma and prejudice against women who
use drugs, especially if they are pregnant or have children, overall
there is greater acceptance of women’s drug use than it was several
decades ago (25). Moreover, women have much greater access to
various drugs of abuse than they used to have. Finally, over the
past couple of decades, new research has suggested some neuro-
biological factors that could also contribute to sex differences in
drug addiction. For example, there is evidence that the dopamine
system, which for decades has been strongly implicated in drug
reinforcement, is sexually dimorphic. The number of dopaminer-
gic neurons, the density of the dopaminergic terminals, as well as
responsiveness of the dopaminergic system to drugs of abuse, have
been shown to differ between males and females and they have
been shown to be modulated by sex steroid hormones, especially
estrogen (22, 26, 27). All these psychological, socio-cultural, and
biological factors that contribute to sex differences in drug use
and drug dependence should be considered while evaluating and
treating individuals with drug addiction problems.
Our research has focused specifically on addiction to nicotine
partly because it is a significant problem in schizophrenia. In the
general population, still more men than women smoke cigarettes,
but this gap is decreasing steadily. Moreover, studies show that
women become dependent faster and have more difficulties quit-
ting the habit thanmen (28). The difficulty quitting and the higher
relapse rates have been linked to greater levels of drug craving,
although evidence is still equivocal. For example, we examined
sex differences in cue-induced craving for cigarettes in non-
deprived smokers and did not find any differences between men
andwomen (29). Therewere, however, fluctuations in the craving-
related fMRI activations across the menstrual cycle in women.
I should highlight that in our study we tested only non-deprived
smokers, while studies that have reported sex differences, typically
assessed craving following a period of abstinence [e.g., Ref. (30,
31)]. Indeed, some studies suggest that men are more sensitive
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to cue-induced craving, while women react stronger to stress-
induced craving [e.g., Ref. (32)]. These and similar studies may
be helpful in developing gender-sensitive treatment programs.
I presented just two examples of neuropsychiatric problems
where unraveling sex differences may benefit women and deepen
our understanding of the disorders. For instance, several promis-
ing clinical trials have already been performed with low doses
of estradiol to treat women and men with schizophrenia (19,
33). In terms of drug addiction, most rehabilitation programs
are still based on a male model, but it is recognized that
women may require additional support (e.g., family planning,
childcare services) and approaches that emphasize stress reduc-
tion (34).
Before closing I would like to mention gender, feminin-
ity/masculinity and related variables, which have been almost
entirely absent from the neuroscience research, with a few excep-
tions. For example, in one early study, Cahill et al. (35) demon-
strated that although no differences were detected between sexes
in emotional memory, when gender was taken into consider-
ation, individuals with more masculine traits showed superior
recall of central emotional information, whereas individuals with
more feminine traits exhibited better recall of peripheral details.
More recent neuroanatomical studies reveal comparable results.
Thus, a study in healthy adults showed that identification with
more feminine traits correlated with greater straight gyrus volume
(part of the ventral frontal cortex) and with better performance
on a social cognition task [interpersonal perception task; (36)].
A different study, in children, reported that higher masculinity
predicted greater volumes ofwhitematter in the frontal lobe, while
higher femininity predicted greater volumes of gray matter in the
temporal lobe (37). These studies point to the possibility that even
though sex and gender are closely related, in some situations,
gender differences may be more important than sex differences
and thus both should be studied in human participants. However,
we need better gendermeasures, asmany tests and questionnaires,
such as the popular Bem Sex Role Inventory (38) were developed
in 1970s.
To conclude, neurocognitive, neurobiological, and clinical
studies that do not include female participants (animal or human)
present only half of the story, the male part. In some cases, this
may not be a problem, but in many it can deter us from scientific
progress in understanding etiology, and in developing successful
treatments for neurological and neuropsychiatric disorders in
men and women. Studies that do not include females are only
half-truth, and as Cahill (39) so eloquently stated using a Yiddish
proverb – “A half-truth is a whole lie.”
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